APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sacubitril Valsartan Sodium Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Sacubitril Valsartan Sodium Drugs Industry Growth and Trends Forecast to 2032

27 December 2025121 pages

Choose your research edition.

Industry ResearchSacubitril Valsartan Sodium Drugs Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Sacubitril Valsartan Sodium Drugs Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Sacubitril Valsartan Sodium Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sacubitril Valsartan Sodium Drugs Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Sacubitril Valsartan Sodium Drugs Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Sacubitril Valsartan Sodium Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Sacubitril Valsartan Sodium Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Sacubitril Valsartan Sodium Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sacubitril Valsartan Sodium Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sacubitril Valsartan Sodium Drugs include Addii Biotech, Arlak Corazon, Cipla, Farmanova pharma, General Pharmaceuticals, MSN, Novartis, Sanof and Changzhou Pharmaceutical Factory, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Sacubitril Valsartan Sodium Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Sacubitril Valsartan Sodium Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Sacubitril Valsartan Sodium Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Sacubitril Valsartan Sodium Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Sacubitril Valsartan Sodium Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Sacubitril Valsartan Sodium Drugs Market by Company

Addii Biotech

Arlak Corazon

Cipla

Farmanova pharma

General Pharmaceuticals

MSN

Novartis

Sanof

Changzhou Pharmaceutical Factory

Chengdu Brilliant Pharmaceutical

TC Pharmaceuticals (Jiangsu)

Sino Therapeutics

Kelun Pharmaceutical

Qilu Pharmaceutical

Shenzhen Salubris Pharmaceuticals

CSPC Ouyi Pharmaceutical

Sihuan Pharmaceutical

Zhejiang AngLiKang Pharmaceutical

Zhejiang Nord Pharmaceutical

Chia Tai Tianqing Pharmaceutical

Sacubitril Valsartan Sodium Drugs Segment by Type

Tablets

Oral Pellets

Sacubitril Valsartan Sodium Drugs Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Sacubitril Valsartan Sodium Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sacubitril Valsartan Sodium Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sacubitril Valsartan Sodium Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sacubitril Valsartan Sodium Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Sacubitril Valsartan Sodium Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Sacubitril Valsartan Sodium Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tablets Table 2. Major Company of Oral Pellets Table 3. Global Sacubitril Valsartan Sodium Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Sacubitril Valsartan Sodium Drugs Sales by Type (2021-2026) & (K Units) Table 5. Global Sacubitril Valsartan Sodium Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Sacubitril Valsartan Sodium Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Sacubitril Valsartan Sodium Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global Sacubitril Valsartan Sodium Drugs Price by Type (2021-2026) & (US$/Unit) Table 9. Global Sacubitril Valsartan Sodium Drugs Sales by Type (2027-2032) & (K Units) Table 10. Global Sacubitril Valsartan Sodium Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Sacubitril Valsartan Sodium Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Sacubitril Valsartan Sodium Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global Sacubitril Valsartan Sodium Drugs Price by Type (2027-2032) & (US$/Unit) Table 14. North America Sacubitril Valsartan Sodium Drugs Sales by Type (2021-2026) & (K Units) Table 15. North America Sacubitril Valsartan Sodium Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Sacubitril Valsartan Sodium Drugs Sales by Type (2021-2026) & (K Units) Table 17. Europe Sacubitril Valsartan Sodium Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Sacubitril Valsartan Sodium Drugs Sales by Type (2021-2026) & (K Units) Table 21. Latin America Sacubitril Valsartan Sodium Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Sacubitril Valsartan Sodium Drugs Industry Trends Table 25. Sacubitril Valsartan Sodium Drugs Industry Drivers Table 26. Sacubitril Valsartan Sodium Drugs Industry Opportunities and Challenges Table 27. Sacubitril Valsartan Sodium Drugs Industry Restraints Table 28. Global Sacubitril Valsartan Sodium Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Sacubitril Valsartan Sodium Drugs Revenue Market Share by Company (2021-2026) Table 30. Global Sacubitril Valsartan Sodium Drugs Sales by Company (2021-2026) & (K Units) Table 31. Global Sacubitril Valsartan Sodium Drugs Sales Share by Company (2021-2026) Table 32. Global Sacubitril Valsartan Sodium Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Sacubitril Valsartan Sodium Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Sacubitril Valsartan Sodium Drugs Major Company Production Sites and Headquarters Table 35. Global Sacubitril Valsartan Sodium Drugs Company, Product Type & Application Table 36. Global Sacubitril Valsartan Sodium Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Sacubitril Valsartan Sodium Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Sacubitril Valsartan Sodium Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Sacubitril Valsartan Sodium Drugs Sales by Region (2021-2026) & (K Units) Table 41. Global Sacubitril Valsartan Sodium Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Sacubitril Valsartan Sodium Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Sacubitril Valsartan Sodium Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global Sacubitril Valsartan Sodium Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Sacubitril Valsartan Sodium Drugs Sales by Region (2027-2032) & (K Units) Table 46. Global Sacubitril Valsartan Sodium Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Sacubitril Valsartan Sodium Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Sacubitril Valsartan Sodium Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global Sacubitril Valsartan Sodium Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Sacubitril Valsartan Sodium Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Sacubitril Valsartan Sodium Drugs Sales by Application (2021-2026) & (K Units) Table 52. Global Sacubitril Valsartan Sodium Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Sacubitril Valsartan Sodium Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Sacubitril Valsartan Sodium Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global Sacubitril Valsartan Sodium Drugs Price by Application (2021-2026) & (US$/Unit) Table 56. Global Sacubitril Valsartan Sodium Drugs Sales by Application (2027-2032) & (K Units) Table 57. Global Sacubitril Valsartan Sodium Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Sacubitril Valsartan Sodium Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Sacubitril Valsartan Sodium Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global Sacubitril Valsartan Sodium Drugs Price by Application (2027-2032) & (US$/Unit) Table 61. North America Sacubitril Valsartan Sodium Drugs Sales by Application (2021-2026) & (K Units) Table 62. North America Sacubitril Valsartan Sodium Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Sacubitril Valsartan Sodium Drugs Sales by Application (2021-2026) & (K Units) Table 64. Europe Sacubitril Valsartan Sodium Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Sacubitril Valsartan Sodium Drugs Sales by Application (2021-2026) & (K Units) Table 68. Latin America Sacubitril Valsartan Sodium Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Addii Biotech Company Information Table 72. Addii Biotech Business Overview Table 73. Addii Biotech Sacubitril Valsartan Sodium Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Addii Biotech Sacubitril Valsartan Sodium Drugs Product Portfolio Table 75. Addii Biotech Recent Development Table 76. Arlak Corazon Company Information Table 77. Arlak Corazon Business Overview Table 78. Arlak Corazon Sacubitril Valsartan Sodium Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Arlak Corazon Sacubitril Valsartan Sodium Drugs Product Portfolio Table 80. Arlak Corazon Recent Development Table 81. Cipla Company Information Table 82. Cipla Business Overview Table 83. Cipla Sacubitril Valsartan Sodium Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Cipla Sacubitril Valsartan Sodium Drugs Product Portfolio Table 85. Cipla Recent Development Table 86. Farmanova pharma Company Information Table 87. Farmanova pharma Business Overview Table 88. Farmanova pharma Sacubitril Valsartan Sodium Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Farmanova pharma Sacubitril Valsartan Sodium Drugs Product Portfolio Table 90. Farmanova pharma Recent Development Table 91. General Pharmaceuticals Company Information Table 92. General Pharmaceuticals Business Overview Table 93. General Pharmaceuticals Sacubitril Valsartan Sodium Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. General Pharmaceuticals Sacubitril Valsartan Sodium Drugs Product Portfolio Table 95. General Pharmaceuticals Recent Development Table 96. MSN Company Information Table 97. MSN Business Overview Table 98. MSN Sacubitril Valsartan Sodium Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. MSN Sacubitril Valsartan Sodium Drugs Product Portfolio Table 100. MSN Recent Development Table 101. Novartis Company Information Table 102. Novartis Business Overview Table 103. Novartis Sacubitril Valsartan Sodium Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Novartis Sacubitril Valsartan Sodium Drugs Product Portfolio Table 105. Novartis Recent Development Table 106. Sanof Company Information Table 107. Sanof Business Overview Table 108. Sanof Sacubitril Valsartan Sodium Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Sanof Sacubitril Valsartan Sodium Drugs Product Portfolio Table 110. Sanof Recent Development Table 111. Changzhou Pharmaceutical Factory Company Information Table 112. Changzhou Pharmaceutical Factory Business Overview Table 113. Changzhou Pharmaceutical Factory Sacubitril Valsartan Sodium Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Changzhou Pharmaceutical Factory Sacubitril Valsartan Sodium Drugs Product Portfolio Table 115. Changzhou Pharmaceutical Factory Recent Development Table 116. Chengdu Brilliant Pharmaceutical Company Information Table 117. Chengdu Brilliant Pharmaceutical Business Overview Table 118. Chengdu Brilliant Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Chengdu Brilliant Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio Table 120. Chengdu Brilliant Pharmaceutical Recent Development Table 121. TC Pharmaceuticals (Jiangsu) Company Information Table 122. TC Pharmaceuticals (Jiangsu) Business Overview Table 123. TC Pharmaceuticals (Jiangsu) Sacubitril Valsartan Sodium Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. TC Pharmaceuticals (Jiangsu) Sacubitril Valsartan Sodium Drugs Product Portfolio Table 125. TC Pharmaceuticals (Jiangsu) Recent Development Table 126. Sino Therapeutics Company Information Table 127. Sino Therapeutics Business Overview Table 128. Sino Therapeutics Sacubitril Valsartan Sodium Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Sino Therapeutics Sacubitril Valsartan Sodium Drugs Product Portfolio Table 130. Sino Therapeutics Recent Development Table 131. Kelun Pharmaceutical Company Information Table 132. Kelun Pharmaceutical Business Overview Table 133. Kelun Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Kelun Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio Table 135. Kelun Pharmaceutical Recent Development Table 136. Qilu Pharmaceutical Company Information Table 137. Qilu Pharmaceutical Business Overview Table 138. Qilu Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Qilu Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio Table 140. Qilu Pharmaceutical Recent Development Table 141. Shenzhen Salubris Pharmaceuticals Company Information Table 142. Shenzhen Salubris Pharmaceuticals Business Overview Table 143. Shenzhen Salubris Pharmaceuticals Sacubitril Valsartan Sodium Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Shenzhen Salubris Pharmaceuticals Sacubitril Valsartan Sodium Drugs Product Portfolio Table 145. Shenzhen Salubris Pharmaceuticals Recent Development Table 146. CSPC Ouyi Pharmaceutical Company Information Table 147. CSPC Ouyi Pharmaceutical Business Overview Table 148. CSPC Ouyi Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. CSPC Ouyi Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio Table 150. CSPC Ouyi Pharmaceutical Recent Development Table 151. Sihuan Pharmaceutical Company Information Table 152. Sihuan Pharmaceutical Business Overview Table 153. Sihuan Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Sihuan Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio Table 155. Sihuan Pharmaceutical Recent Development Table 156. Zhejiang AngLiKang Pharmaceutical Company Information Table 157. Zhejiang AngLiKang Pharmaceutical Business Overview Table 158. Zhejiang AngLiKang Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Zhejiang AngLiKang Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio Table 160. Zhejiang AngLiKang Pharmaceutical Recent Development Table 161. Zhejiang Nord Pharmaceutical Company Information Table 162. Zhejiang Nord Pharmaceutical Business Overview Table 163. Zhejiang Nord Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 164. Zhejiang Nord Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio Table 165. Zhejiang Nord Pharmaceutical Recent Development Table 166. Chia Tai Tianqing Pharmaceutical Company Information Table 167. Chia Tai Tianqing Pharmaceutical Business Overview Table 168. Chia Tai Tianqing Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 169. Chia Tai Tianqing Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio Table 170. Chia Tai Tianqing Pharmaceutical Recent Development Table 171. North America Sacubitril Valsartan Sodium Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. North America Sacubitril Valsartan Sodium Drugs Sales by Country (2021-2026) & (K Units) Table 173. North America Sacubitril Valsartan Sodium Drugs Sales Market Share by Country (2021-2026) Table 174. North America Sacubitril Valsartan Sodium Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 175. North America Sacubitril Valsartan Sodium Drugs Sales Market Share Forecast by Country (2027-2032) Table 176. North America Sacubitril Valsartan Sodium Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. North America Sacubitril Valsartan Sodium Drugs Market Size by Country (2021-2026) & (US$ Million) Table 178. North America Sacubitril Valsartan Sodium Drugs Market Share by Country (2021-2026) Table 179. North America Sacubitril Valsartan Sodium Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. North America Sacubitril Valsartan Sodium Drugs Market Share Forecast by Country (2027-2032) Table 181. Europe Sacubitril Valsartan Sodium Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 182. Europe Sacubitril Valsartan Sodium Drugs Sales by Country (2021-2026) & (K Units) Table 183. Europe Sacubitril Valsartan Sodium Drugs Sales Market Share by Country (2021-2026) Table 184. Europe Sacubitril Valsartan Sodium Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 185. Europe Sacubitril Valsartan Sodium Drugs Sales Market Share Forecast by Country (2027-2032) Table 186. Europe Sacubitril Valsartan Sodium Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Europe Sacubitril Valsartan Sodium Drugs Market Size by Country (2021-2026) & (US$ Million) Table 188. Europe Sacubitril Valsartan Sodium Drugs Market Share by Country (2021-2026) Table 189. Europe Sacubitril Valsartan Sodium Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Europe Sacubitril Valsartan Sodium Drugs Market Share Forecast by Country (2027-2032) Table 191. Asia-Pacific Sacubitril Valsartan Sodium Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 192. Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales by Country (2021-2026) & (K Units) Table 193. Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales Market Share by Country (2021-2026) Table 194. Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 195. Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales Market Share Forecast by Country (2027-2032) Table 196. Asia-Pacific Sacubitril Valsartan Sodium Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Asia-Pacific Sacubitril Valsartan Sodium Drugs Market Size by Country (2021-2026) & (US$ Million) Table 198. Asia-Pacific Sacubitril Valsartan Sodium Drugs Market Share by Country (2021-2026) Table 199. Asia-Pacific Sacubitril Valsartan Sodium Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Asia-Pacific Sacubitril Valsartan Sodium Drugs Market Share Forecast by Country (2027-2032) Table 201. Latin America Sacubitril Valsartan Sodium Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 202. Latin America Sacubitril Valsartan Sodium Drugs Sales by Country (2021-2026) & (K Units) Table 203. Latin America Sacubitril Valsartan Sodium Drugs Sales Market Share by Country (2021-2026) Table 204. Latin America Sacubitril Valsartan Sodium Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 205. Latin America Sacubitril Valsartan Sodium Drugs Sales Market Share Forecast by Country (2027-2032) Table 206. Latin America Sacubitril Valsartan Sodium Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 207. Latin America Sacubitril Valsartan Sodium Drugs Market Size by Country (2021-2026) & (US$ Million) Table 208. Latin America Sacubitril Valsartan Sodium Drugs Market Share by Country (2021-2026) Table 209. Latin America Sacubitril Valsartan Sodium Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 210. Latin America Sacubitril Valsartan Sodium Drugs Market Share Forecast by Country (2027-2032) Table 211. Middle East and Africa Sacubitril Valsartan Sodium Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 212. Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales by Country (2021-2026) & (K Units) Table 213. Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales Market Share by Country (2021-2026) Table 214. Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 215. Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales Market Share Forecast by Country (2027-2032) Table 216. Middle East and Africa Sacubitril Valsartan Sodium Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 217. Middle East and Africa Sacubitril Valsartan Sodium Drugs Market Size by Country (2021-2026) & (US$ Million) Table 218. Middle East and Africa Sacubitril Valsartan Sodium Drugs Market Share by Country (2021-2026) Table 219. Middle East and Africa Sacubitril Valsartan Sodium Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 220. Middle East and Africa Sacubitril Valsartan Sodium Drugs Market Share Forecast by Country (2027-2032) Table 221. Key Raw Materials Table 222. Raw Materials Key Suppliers Table 223. Sacubitril Valsartan Sodium Drugs Distributors List Table 224. Sacubitril Valsartan Sodium Drugs Customers List Table 225. Research Programs/Design for This Report Table 226. Authors List of This Report Table 227. Secondary Sources Table 228. Primary Sources List of Figures Figure 1. Sacubitril Valsartan Sodium Drugs Image Figure 2. Global Sacubitril Valsartan Sodium Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sacubitril Valsartan Sodium Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Sacubitril Valsartan Sodium Drugs Sales (2021-2032) & (K Units) Figure 5. Tablets Image Figure 6. Global Tablets Sales YoY Growth (2021-2032) & (K Units) Figure 7. Oral Pellets Image Figure 8. Global Oral Pellets Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Sacubitril Valsartan Sodium Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Sacubitril Valsartan Sodium Drugs Market Share by Type 2025 VS 2032 Figure 11. North America Sacubitril Valsartan Sodium Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America Sacubitril Valsartan Sodium Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe Sacubitril Valsartan Sodium Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Sacubitril Valsartan Sodium Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Sacubitril Valsartan Sodium Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Sacubitril Valsartan Sodium Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Sacubitril Valsartan Sodium Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital and Clinic Image Figure 24. Global Hospital and Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 25. Retail Pharmacies Image Figure 26. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Sacubitril Valsartan Sodium Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Sacubitril Valsartan Sodium Drugs Market Share by Application 2025 VS 2032 Figure 31. North America Sacubitril Valsartan Sodium Drugs Sales Market Share in Volume by Application in 2025 Figure 32. North America Sacubitril Valsartan Sodium Drugs Sales Market Share in Value by Application in 2025 Figure 33. Europe Sacubitril Valsartan Sodium Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Europe Sacubitril Valsartan Sodium Drugs Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales Market Share in Value by Application in 2025 Figure 37. Latin America Sacubitril Valsartan Sodium Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Sacubitril Valsartan Sodium Drugs Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales Market Share in Value by Application in 2025 Figure 41. North America Sacubitril Valsartan Sodium Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Sacubitril Valsartan Sodium Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Sacubitril Valsartan Sodium Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Sacubitril Valsartan Sodium Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Sacubitril Valsartan Sodium Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Sacubitril Valsartan Sodium Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Sacubitril Valsartan Sodium Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Sacubitril Valsartan Sodium Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Sacubitril Valsartan Sodium Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Sacubitril Valsartan Sodium Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Sacubitril Valsartan Sodium Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Sacubitril Valsartan Sodium Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Sacubitril Valsartan Sodium Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Sacubitril Valsartan Sodium Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Sacubitril Valsartan Sodium Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Sacubitril Valsartan Sodium Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Sacubitril Valsartan Sodium Drugs Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Sacubitril Valsartan Sodium Drugs Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Oral Pellets
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Addii Biotech
  • Arlak Corazon
  • Cipla
  • Farmanova pharma
  • General Pharmaceuticals
  • MSN
  • Novartis
  • Sanof
  • Changzhou Pharmaceutical Factory
  • Chengdu Brilliant Pharmaceutical
  • TC Pharmaceuticals (Jiangsu)
  • Sino Therapeutics
  • Kelun Pharmaceutical
  • Qilu Pharmaceutical
  • Shenzhen Salubris Pharmaceuticals
  • CSPC Ouyi Pharmaceutical
  • Sihuan Pharmaceutical
  • Zhejiang AngLiKang Pharmaceutical
  • Zhejiang Nord Pharmaceutical
  • Chia Tai Tianqing Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sacubitril Valsartan Sodium Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Sacubitril Valsartan Sodium Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Sacubitril Valsartan Sodium Drugs Market by Type
  6. 1.3.1 Tablets
  7. 1.3.2 Oral Pellets
  8. 1.4 Global Sacubitril Valsartan Sodium Drugs Market Size by Type
  9. 1.4.1 Global Sacubitril Valsartan Sodium Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Sacubitril Valsartan Sodium Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Sacubitril Valsartan Sodium Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Sacubitril Valsartan Sodium Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Sacubitril Valsartan Sodium Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Sacubitril Valsartan Sodium Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Sacubitril Valsartan Sodium Drugs Industry Trends
  2. 2.2 Sacubitril Valsartan Sodium Drugs Industry Drivers
  3. 2.3 Sacubitril Valsartan Sodium Drugs Industry Opportunities and Challenges
  4. 2.4 Sacubitril Valsartan Sodium Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Sacubitril Valsartan Sodium Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Sacubitril Valsartan Sodium Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Sacubitril Valsartan Sodium Drugs Price (2021-2026)
  4. 3.4 Global Sacubitril Valsartan Sodium Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sacubitril Valsartan Sodium Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Sacubitril Valsartan Sodium Drugs Company, Product Type & Application
  7. 3.7 Global Sacubitril Valsartan Sodium Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sacubitril Valsartan Sodium Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sacubitril Valsartan Sodium Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Sacubitril Valsartan Sodium Drugs Tier 1, Tier 2, and Tier 3
4 Sacubitril Valsartan Sodium Drugs Regional Status and Outlook
  1. 4.1 Global Sacubitril Valsartan Sodium Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Sacubitril Valsartan Sodium Drugs Historic Market Size by Region
  3. 4.2.1 Global Sacubitril Valsartan Sodium Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Sacubitril Valsartan Sodium Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Sacubitril Valsartan Sodium Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Sacubitril Valsartan Sodium Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Sacubitril Valsartan Sodium Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Sacubitril Valsartan Sodium Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Sacubitril Valsartan Sodium Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Sacubitril Valsartan Sodium Drugs by Application
  1. 5.1 Sacubitril Valsartan Sodium Drugs Market by Application
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Other
  5. 5.2 Global Sacubitril Valsartan Sodium Drugs Market Size by Application
  6. 5.2.1 Global Sacubitril Valsartan Sodium Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Sacubitril Valsartan Sodium Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Sacubitril Valsartan Sodium Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Sacubitril Valsartan Sodium Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Sacubitril Valsartan Sodium Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Sacubitril Valsartan Sodium Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Addii Biotech
  2. 6.1.1 Addii Biotech Company Information
  3. 6.1.2 Addii Biotech Business Overview
  4. 6.1.3 Addii Biotech Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Addii Biotech Sacubitril Valsartan Sodium Drugs Product Portfolio
  6. 6.1.5 Addii Biotech Recent Developments
  7. 6.2 Arlak Corazon
  8. 6.2.1 Arlak Corazon Company Information
  9. 6.2.2 Arlak Corazon Business Overview
  10. 6.2.3 Arlak Corazon Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Arlak Corazon Sacubitril Valsartan Sodium Drugs Product Portfolio
  12. 6.2.5 Arlak Corazon Recent Developments
  13. 6.3 Cipla
  14. 6.3.1 Cipla Company Information
  15. 6.3.2 Cipla Business Overview
  16. 6.3.3 Cipla Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Cipla Sacubitril Valsartan Sodium Drugs Product Portfolio
  18. 6.3.5 Cipla Recent Developments
  19. 6.4 Farmanova pharma
  20. 6.4.1 Farmanova pharma Company Information
  21. 6.4.2 Farmanova pharma Business Overview
  22. 6.4.3 Farmanova pharma Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Farmanova pharma Sacubitril Valsartan Sodium Drugs Product Portfolio
  24. 6.4.5 Farmanova pharma Recent Developments
  25. 6.5 General Pharmaceuticals
  26. 6.5.1 General Pharmaceuticals Company Information
  27. 6.5.2 General Pharmaceuticals Business Overview
  28. 6.5.3 General Pharmaceuticals Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 General Pharmaceuticals Sacubitril Valsartan Sodium Drugs Product Portfolio
  30. 6.5.5 General Pharmaceuticals Recent Developments
  31. 6.6 MSN
  32. 6.6.1 MSN Company Information
  33. 6.6.2 MSN Business Overview
  34. 6.6.3 MSN Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 MSN Sacubitril Valsartan Sodium Drugs Product Portfolio
  36. 6.6.5 MSN Recent Developments
  37. 6.7 Novartis
  38. 6.7.1 Novartis Company Information
  39. 6.7.2 Novartis Business Overview
  40. 6.7.3 Novartis Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Novartis Sacubitril Valsartan Sodium Drugs Product Portfolio
  42. 6.7.5 Novartis Recent Developments
  43. 6.8 Sanof
  44. 6.8.1 Sanof Company Information
  45. 6.8.2 Sanof Business Overview
  46. 6.8.3 Sanof Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sanof Sacubitril Valsartan Sodium Drugs Product Portfolio
  48. 6.8.5 Sanof Recent Developments
  49. 6.9 Changzhou Pharmaceutical Factory
  50. 6.9.1 Changzhou Pharmaceutical Factory Company Information
  51. 6.9.2 Changzhou Pharmaceutical Factory Business Overview
  52. 6.9.3 Changzhou Pharmaceutical Factory Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Changzhou Pharmaceutical Factory Sacubitril Valsartan Sodium Drugs Product Portfolio
  54. 6.9.5 Changzhou Pharmaceutical Factory Recent Developments
  55. 6.10 Chengdu Brilliant Pharmaceutical
  56. 6.10.1 Chengdu Brilliant Pharmaceutical Company Information
  57. 6.10.2 Chengdu Brilliant Pharmaceutical Business Overview
  58. 6.10.3 Chengdu Brilliant Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Chengdu Brilliant Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio
  60. 6.10.5 Chengdu Brilliant Pharmaceutical Recent Developments
  61. 6.11 TC Pharmaceuticals (Jiangsu)
  62. 6.11.1 TC Pharmaceuticals (Jiangsu) Company Information
  63. 6.11.2 TC Pharmaceuticals (Jiangsu) Business Overview
  64. 6.11.3 TC Pharmaceuticals (Jiangsu) Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 TC Pharmaceuticals (Jiangsu) Sacubitril Valsartan Sodium Drugs Product Portfolio
  66. 6.11.5 TC Pharmaceuticals (Jiangsu) Recent Developments
  67. 6.12 Sino Therapeutics
  68. 6.12.1 Sino Therapeutics Company Information
  69. 6.12.2 Sino Therapeutics Business Overview
  70. 6.12.3 Sino Therapeutics Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Sino Therapeutics Sacubitril Valsartan Sodium Drugs Product Portfolio
  72. 6.12.5 Sino Therapeutics Recent Developments
  73. 6.13 Kelun Pharmaceutical
  74. 6.13.1 Kelun Pharmaceutical Company Information
  75. 6.13.2 Kelun Pharmaceutical Business Overview
  76. 6.13.3 Kelun Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Kelun Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio
  78. 6.13.5 Kelun Pharmaceutical Recent Developments
  79. 6.14 Qilu Pharmaceutical
  80. 6.14.1 Qilu Pharmaceutical Company Information
  81. 6.14.2 Qilu Pharmaceutical Business Overview
  82. 6.14.3 Qilu Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Qilu Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio
  84. 6.14.5 Qilu Pharmaceutical Recent Developments
  85. 6.15 Shenzhen Salubris Pharmaceuticals
  86. 6.15.1 Shenzhen Salubris Pharmaceuticals Company Information
  87. 6.15.2 Shenzhen Salubris Pharmaceuticals Business Overview
  88. 6.15.3 Shenzhen Salubris Pharmaceuticals Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Shenzhen Salubris Pharmaceuticals Sacubitril Valsartan Sodium Drugs Product Portfolio
  90. 6.15.5 Shenzhen Salubris Pharmaceuticals Recent Developments
  91. 6.16 CSPC Ouyi Pharmaceutical
  92. 6.16.1 CSPC Ouyi Pharmaceutical Company Information
  93. 6.16.2 CSPC Ouyi Pharmaceutical Business Overview
  94. 6.16.3 CSPC Ouyi Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 CSPC Ouyi Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio
  96. 6.16.5 CSPC Ouyi Pharmaceutical Recent Developments
  97. 6.17 Sihuan Pharmaceutical
  98. 6.17.1 Sihuan Pharmaceutical Company Information
  99. 6.17.2 Sihuan Pharmaceutical Business Overview
  100. 6.17.3 Sihuan Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Sihuan Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio
  102. 6.17.5 Sihuan Pharmaceutical Recent Developments
  103. 6.18 Zhejiang AngLiKang Pharmaceutical
  104. 6.18.1 Zhejiang AngLiKang Pharmaceutical Company Information
  105. 6.18.2 Zhejiang AngLiKang Pharmaceutical Business Overview
  106. 6.18.3 Zhejiang AngLiKang Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Zhejiang AngLiKang Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio
  108. 6.18.5 Zhejiang AngLiKang Pharmaceutical Recent Developments
  109. 6.19 Zhejiang Nord Pharmaceutical
  110. 6.19.1 Zhejiang Nord Pharmaceutical Company Information
  111. 6.19.2 Zhejiang Nord Pharmaceutical Business Overview
  112. 6.19.3 Zhejiang Nord Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Zhejiang Nord Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio
  114. 6.19.5 Zhejiang Nord Pharmaceutical Recent Developments
  115. 6.20 Chia Tai Tianqing Pharmaceutical
  116. 6.20.1 Chia Tai Tianqing Pharmaceutical Company Information
  117. 6.20.2 Chia Tai Tianqing Pharmaceutical Business Overview
  118. 6.20.3 Chia Tai Tianqing Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Chia Tai Tianqing Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio
  120. 6.20.5 Chia Tai Tianqing Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Sacubitril Valsartan Sodium Drugs Sales by Country
  2. 7.1.1 North America Sacubitril Valsartan Sodium Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Sacubitril Valsartan Sodium Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Sacubitril Valsartan Sodium Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Sacubitril Valsartan Sodium Drugs Market Size by Country
  6. 7.2.1 North America Sacubitril Valsartan Sodium Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Sacubitril Valsartan Sodium Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Sacubitril Valsartan Sodium Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Sacubitril Valsartan Sodium Drugs Sales by Country
  2. 8.1.1 Europe Sacubitril Valsartan Sodium Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Sacubitril Valsartan Sodium Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Sacubitril Valsartan Sodium Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Sacubitril Valsartan Sodium Drugs Market Size by Country
  6. 8.2.1 Europe Sacubitril Valsartan Sodium Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Sacubitril Valsartan Sodium Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Sacubitril Valsartan Sodium Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Sacubitril Valsartan Sodium Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Sacubitril Valsartan Sodium Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Sacubitril Valsartan Sodium Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Sacubitril Valsartan Sodium Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Sacubitril Valsartan Sodium Drugs Sales by Country
  2. 10.1.1 South America Sacubitril Valsartan Sodium Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Sacubitril Valsartan Sodium Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Sacubitril Valsartan Sodium Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Sacubitril Valsartan Sodium Drugs Market Size by Country
  6. 10.2.1 South America Sacubitril Valsartan Sodium Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Sacubitril Valsartan Sodium Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Sacubitril Valsartan Sodium Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Sacubitril Valsartan Sodium Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Sacubitril Valsartan Sodium Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Sacubitril Valsartan Sodium Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Sacubitril Valsartan Sodium Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Sacubitril Valsartan Sodium Drugs Value Chain Analysis
  2. 12.1.1 Sacubitril Valsartan Sodium Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Sacubitril Valsartan Sodium Drugs Production Mode & Process
  7. 12.2 Sacubitril Valsartan Sodium Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Sacubitril Valsartan Sodium Drugs Distributors
  10. 12.2.3 Sacubitril Valsartan Sodium Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst